» Articles » PMID: 28413326

Effect of B-complex Vitamins on the Antifatigue Activity and Bioavailability of Ginsenoside Re After Oral Administration

Overview
Journal J Ginseng Res
Date 2017 Apr 18
PMID 28413326
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Both ginsenoside Re and B-complex vitamins are widely used as nutritional supplements. They are often taken together so as to fully utilize their antifatigue and refreshing effects, respectively. Whether actually a drug-nutrient interaction exists between ginsenoside Re and B-complex vitamins is still unknown. The objective of this study was to simultaneously investigate the effect of B-complex vitamins on the antifatigue activity and bioavailability of ginsenoside Re after their oral administration. The study results will provide valuable theoretical guidance for the combined utilization of ginseng and B-complex vitamins.

Methods: Ginsenoside Re with or without B-complex vitamins was orally administered to mice to evaluate its antifatigue effects and to rats to evaluate its bioavailability. The antifatigue activity was evaluated by the weight-loaded swimming test and biochemical parameters, including hepatic glycogen, plasma urea nitrogen, and blood lactic acid. The concentration of ginsenoside Re in plasma was determined by liquid chromatography-tandem mass spectrometry.

Results: No antifatigue effect of ginsenoside Re was noted when ginsenoside Re in combination with B-complex vitamins was orally administered to mice. B-complex vitamins caused to a reduction in the bioavailability of ginsenoside Re with the area under the concentration-time curve from zero to infinity markedly decreasing from 11,830.85 ± 2,366.47 h·ng/mL to 890.55 ± 372.94 h·ng/mL.

Conclusion: The results suggested that there were pharmacokinetic and pharmacodynamic drug-nutrient interactions between ginsenoside Re and B-complex vitamins. B-complex vitamins can significantly weaken the antifatigue effect and decrease the bioavailability of ginsenoside Re when simultaneously administered orally.

Citing Articles

The Impact of Vitamin Deficiencies on Oral Manifestations in Children.

Lesic S, Ivanisevic Z, Spiljak B, Tomas M, Sostaric M, Vcev A Dent J (Basel). 2024; 12(4).

PMID: 38668021 PMC: 11049216. DOI: 10.3390/dj12040109.


Pharmacological Properties of Ginsenoside Re.

Gao X, Liu G, Zhang J, Wang L, Xu C, Yan Z Front Pharmacol. 2022; 13:754191.

PMID: 35462899 PMC: 9019721. DOI: 10.3389/fphar.2022.754191.


Protective effects of 7-hydroxyethyl chrysin on rats with exercise-induced fatigue in hypobaric hypoxia environment.

Miao L, Zhao T, Gao Y, Jing L, Huang Q, Ma H Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022; 50(5):575-581.

PMID: 34986529 PMC: 8732255. DOI: 10.3724/zdxbyxb-2021-0319.

References
1.
Xiong J, Guo J, Huang L, Meng B, Ping Q . The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats. Drug Dev Ind Pharm. 2008; 34(1):65-72. DOI: 10.1080/03639040701508292. View

2.
Shin B, Kwon S, Park J . Chemical diversity of ginseng saponins from Panax ginseng. J Ginseng Res. 2016; 39(4):287-98. PMC: 4593792. DOI: 10.1016/j.jgr.2014.12.005. View

3.
Wang W, Liao Q, Quan L, Liu C, Chang Q, Liu X . The effect of Acorus gramineus on the bioavailabilities and brain concentrations of ginsenosides Rg1, Re and Rb1 after oral administration of Kai-Xin-San preparations in rats. J Ethnopharmacol. 2010; 131(2):313-20. DOI: 10.1016/j.jep.2010.06.034. View

4.
Patel J, Buddha B, Dey S, Pal D, Mitra A . In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther. 2004; 11(4):262-77. DOI: 10.1097/01.mjt.0000101827.94820.22. View

5.
Xiong J, Guo J, Huang L, Meng B, Ping Q . Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginseng. Int J Pharm. 2008; 360(1-2):191-6. DOI: 10.1016/j.ijpharm.2008.04.016. View